Scientists have uncovered a potential approach to treat one of the commonest causes of dementia and stroke in older people.
Studies with rats found the treatment can reverse changes in blood vessels in the brain associated with the condition, called cerebral small vessel disease.
Treatment also prevents damage to brain cells caused by these blood vessel changes, raising hope that it could offer a therapy for dementia.
Small vessel disease, or SVD, is a major cause of dementia and can also worsen the symptoms of Alzheimer’s disease. It is responsible for almost half of all dementia cases in the UK and is a major cause of stroke, accounting for around one in five cases.
Patients with SVD are diagnosed from brain scans, which detect damage to white matter – a key component of the brain’s wiring.
Until now, it was not known how changes in small blood vessels in the brain associated with SVD can cause damage to brain cells.
A team led by the University of Edinburgh found that SVD occurs when cells that line the small blood vessels in the brain become dysfunctional. This causes them to secrete a molecule into the brain.
The molecule stops production of the protective layer that surrounds brain cells – called myelin – which leads to brain damage.
Treating rats with drugs that stop blood vessel cells from becoming dysfunctional reversed the symptoms of SVD and prevented brain damage, tests found.
Researchers say that further studies will need to test whether the treatment also works when the disease is firmly established. They will also need to check if the treatment can reverse the symptoms of dementia.
Dementia is one of the biggest problems facing society, as people live longer and the population ages. Estimates indicate there are almost 47 million people living with dementia worldwide and the numbers affected are expected to double every 20 years, rising to more than 115 million by 2050.
The research, published in Science Translational Medicine, was carried out at the Medical Research Council Centre for Regenerative Medicine and the UK Dementia Research Institute at the University of Edinburgh. It was funded by the MRC, Alzheimer’s Research UK and Fondation Leducq.
Professor Anna Williams, Group Leader at the University of Edinburgh’s MRC Centre for Regenerative Medicine, said: “This important research helps us understand why small vessel disease happens, providing a direct link between small blood vessels and changes in the brain that are linked to dementia. It also shows that these changes may be reversible, which paves the way for potential treatments.”
Dr Sara Imarisio, Head of Research at Alzheimer’s Research UK said: “Changes to the blood supply in the brain play an important role in Alzheimer’s disease as well as being a direct cause of vascular dementia. This pioneering research highlights a molecular link between changes to small blood vessels in the brain and damage to the insulating ‘white matter’ that helps nerve cells to send signals around the brain.
“The findings highlight a promising direction for research into treatments that could limit the damaging effects of blood vessel changes and help keep nerve cells functioning for longer. There are currently no drugs that slow down or stop Alzheimer’s disease and no treatments to help people living with vascular dementia. Alzheimer’s Research UK is very pleased to have helped fund this innovative research, which is only possible thanks to the work of our dedicated supporters.”
The Latest on: Small vessel disease
via Google News
The Latest on: Small vessel disease
- Secrets to a Healthy Hearton January 27, 2021 at 9:28 am
Stenting can save your life during a heart attack, but new research explores whether it can prevent one if you have stable heart disease.
- FLEX Vessel Preptm System Data Presented During Leipzig Interventional Course (LINC) 2021on January 27, 2021 at 7:39 am
VentureMed Group, Inc. (VentureMed), a privately-held medical device innovator, announced today that data from three studies evaluating the use of its FLEX Vessel Prep (VP) System were presented ...
- Researchers Identify Genetic Risk Factor for Stroke in Older Adultson January 21, 2021 at 6:32 am
NOTCH3 variants are a common genetic risk factor for stroke in patients older than age 65, a finding that could help improve outcomes for the condition.
- CLBS Stock: Why Caladrius Biosciences Is Soaring Todayon January 20, 2021 at 7:32 am
Stock Market News, Stock Advice & Trading Tips Shares of Caladrius Biosciences (NASDAQ:CLBS) are up more than twofold in ...
- Research identifies genetic risk factor for strokeon January 19, 2021 at 9:47 am
A team of Geisinger researchers has identified a common genetic variant as a risk factor for stroke, especially in patients older than 65.
- Decreased Retinal Vessel, Perfusion Densities Found in Those With Parkinson Diseaseon January 4, 2021 at 11:10 am
Although the underlying cause of PD is not well understood and no universally accepted biomarkers exist for an in vivo diagnosis of PD, evidence points to cerebral small vessel disease as a ...
- Vascular Disease and Multiple Sclerosis: A Post-mortem Study Exploring Their Relationshipson November 18, 2020 at 3:41 pm
For each case, formalin-fixed paraffin-embedded tissue from the frontal and occipital white matter, basal ganglia and pons was used to obtain a global cerebral small vessel disease score that ...
- Case 26-2020: A 60-Year-Old Woman with Altered Mental Status and Weakness on the Left Sideon August 20, 2020 at 3:22 am
23 The punctate size of the lesion and its location in the contralateral posterior limb of the internal capsule in this patient with chronic hypertension suggest small-vessel disease ...
- Effects of Clopidogrel Added to Aspirin in Patients with Recent Lacunar Strokeon August 16, 2020 at 12:52 pm
Lacunar infarcts are a frequent type of stroke caused mainly by cerebral small-vessel disease. The effectiveness of antiplatelet therapy for secondary prevention has not been defined. The ...
via Bing News